(c) 2024 PillSync.com

ranolazine tablet extended release

1 INDICATIONS AND USAGE Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. (1)

sun pharmaceutical industries, inc.


3 years ago OVAL ORANGE RL49 ranolazine tablet extended release

OVAL ORANGE RL49

3 years ago OVAL ORANGE RL49 ranolazine tablet extended release

RL49 OVAL ORANGE

16 HOW SUPPLIED/STORAGE AND HANDLING

RANOLAZINE extended-release tablets are supplied as film-coated, oblong-shaped, extended-release tablets in the following strengths: • 500 mg tablets are light orange colored, debossed with “ RL49 ” on one side and plain on the other side. • 1000 mg tablets are pale yellow colored, debossed with “ RL50 ” on one side and plain on the other side.

RANOLAZINE extended-release tablets are available in: Strength NDC Bottle of 60 Tablets (with child-resistant closure) 500 mg 1000 mg 63304-017-60 63304-018-60 Bottle of 180 Tablets (with child-resistant closure) 500 mg 1000 mg 63304-017-28 63304-018-28 Bottle of 500 Tablets 500 mg 1000 mg 63304-017-05 63304-018-05 Store

RANOLAZINE extended-release tablets at 20° C to 25° C (68° F to 77° F). [See USP Controlled Room Temperature.] Keep out of reach of children .


More pills like OVAL RL49












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site